Role Of Cbc Parameters And Crp Test In Assessment And Identification Of Mood Disorders
Keywords:
Complete blood cells, C- reactive Proteins, Mood disorders, Bipolar disordersAbstract
Mood disorders, prevalent global health issues, often suffer from delayed or inaccurate diagnosis due to subjective assessments. Depression and bipolar disorder are the two most common mood disorders worldwide. The aim of this study was to investigate the potential role of CBC parameters and CRP test in the assessment and identification of mood disorders. This cross-sectional study was conducted in the Noble Clinical Lab, Baramati-413102 Maharashtra. It was found that percentage of female among cases group was 55.4% and in control group (healthy) this percentage was 51.8% in comparison to male counterpart. It was concluded that we found various inflammatory indicators associated with mood disorders. The levels of CRP independent risk factors.
Downloads
Metrics
References
Pérez-Sola V, Roca M, Alonso J, Gabilondo A, Hernando T, Sicras-Mainar A, Sicras-Navarro A, Herrera B, Vieta E. Economic impact of treatment-resistant depression: A retrospective observational study. Journal of Affective Disorders. 2021 Dec 1;295:578-86.
Tomasik J, Han SY, Barton-Owen G, Mirea DM, Martin-Key NA, Rustogi N, Lago SG, Olmert T, Cooper JD, Ozcan S, Eljasz P. A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data. Translational psychiatry. 2021 Jan 12;11(1):41.
Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LM, Subramaniapillai M, Gill H, Liu RN, Joseph P. Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis. JAMA psychiatry. 2021 Oct 1;78(10):1079-91.
Possidente C, Fanelli G, Serretti A, Fabbri C. Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses. Neuroscience & Biobehavioral Reviews. 2023 Jun 28:105298.
Solmi M, Fiedorowicz J, Poddighe L, Delogu M, Miola A, Høye A, Heiberg IH, Stubbs B, Smith L, Larsson H, Attar R. Disparities in screening and treatment of cardiovascular diseases in patients with mental disorders across the world: systematic review and meta-analysis of 47 observational studies. American Journal of Psychiatry. 2021 Sep 1;178(9):793-803.
Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, Jones D, Drevets WC, Cowen P, Harrison NA, Pariante CM. Peripheral blood cell–stratified subgroups of inflamed depression. Biological psychiatry. 2020 Jul 15;88(2):185-96.
Wei Y, Wang T, Li G, Feng J, Deng L, Xu H, et al. Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio, lymphocyte/indicators of inflammation in patients with schizophrenia and bipolar disorder. Front Psych. (2022) 13:941728. doi: 10.3389/fpsyt.2022.941728
Dadouli K, Janho MB, Hatziefthimiou A, Voulgaridi I, Piaha K, Anagnostopoulos L, et al. Neutrophil-to-lymphocyte, monocyte-to-lymphocyte, platelet-to-lymphocyte ratio and systemic immune-inflammatory index in different states of bipolar disorder. Brain Sci. (2022) 12:1034. doi: 10.3390/brainsci12081034
Misiak B, Bartoli F, Carrà G, Małecka M, Samochowiec J, Jarosz K, et al. Chemokine alterations in bipolar disorder: a systematic review and meta-analysis. Brain Behav Immun. (2020) 88:870–7. doi: 10.1016/j.bbi.2020.04.013
Pfau ML, Ménard C, Russo SJ. Inflammatory mediators in mood disorders: therapeutic opportunities. Annu Rev Pharmacol Toxicol. (2018) 58:411–28. doi: 10.1146/ annurev-pharmtox-010617-052823
Fernandes BS, Steiner J, Molendijk ML, Dodd S, Nardin P, Goncalves CA, et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. (2016) 3:1147–56. doi: 10.1016/ S2215-0366(16)30370-4
Uyanik V, Tuglu C, Gorgulu Y, Kunduracilar H, Uyanik MS. Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment. Psychiatry Res. (2015) 228:386–92. doi: 10.1016/j.psychres.2015.05.078
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
